AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
AMIA’s comments on the NIH FY27–FY31 Strategic Plan framework urge NIH to prioritize informatics, data science, artificial intelligence, and digital infrastructure as foundational enablers of biomedical research. AMIA recommends strengthening workforce development, modernizing research data resources, advancing interoperable and trustworthy health technologies, and promoting transparent, evidence-based research stewardship. The comments […]
The Friends of ONC letter urges Congress to reject proposed FY27 funding cuts to the Office of the National Coordinator for Health Information Technology (ONC), warning reductions from $69 million to $50 million would undermine interoperability, standards development, and coordination efforts critical to nationwide health data exchange and innovation.
A coalition of 90+ research and patient organizations, including American Medical Informatics Association, opposes the FY 2027 budget proposal cutting the National Institutes of Health by over 12%. The letter warns cuts would halt research, eliminate jobs, and weaken U.S. innovation, urging Congress to fund NIH at $51.3 billion and […]
AMIA provided recommendations on the draft USCDI Version 7 to improve data quality, interoperability, and equity. It emphasizes clearer definitions, inclusion of environmental and social health factors, enhanced provenance, better medication and device tracking, and patient-centered data. AMIA urges ONC to adopt standardized, flexible frameworks supporting nationwide health data exchange.
Patient ID Now is calling on House and Senate appropriators to repeal Section 510 in the FY27 Labor-HHS appropriations bill, which restricts federal action on a national patient identifier. The group argues the decades-old policy contributes to medical errors, higher costs, and privacy risks due to inaccurate patient matching. Removing […]
AMIA's comments on NIH's Draft Controlled-Access Data Policy and revised Genomic Data Sharing Policy call for a flexible, risk-based framework that moves beyond rigid data-type categorizations. Key recommendations include harmonizing NIH data policies, investing in repository infrastructure and workforce capacity, avoiding prescriptive security standards that burden under-resourced institutions, and enabling […]
AMIA joined the Friends of AHRQ coalition in signing a March 2, 2026, letter to Congressional appropriators urging at least $500 million in funding for the Agency for Healthcare Research and Quality (AHRQ) for fiscal year 2027. The letter highlights AHRQ’s essential role in health services and primary care research […]
AMIA submitted comments opposing aspects of the Reimagining and Improving Student Education proposed rule from the Department of Education (DOE). We argued nursing degrees (MSN/DNP) must remain professionally designated, as changes would raise financial barriers, worsen workforce shortages, and conflict with national health and informatics priorities. Maintaining professional nursing education […]
AMIA signed on to support the Joint Public Health Informatics Taskforce (JPHIT) response to the Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity (HTI‑5) Proposed Rule. AMIA endorsed JPHIT’s recommendations to ensure that updates to the ONC Health IT Certification Program maintain strong support for public health […]
AMIA supports the goals of the HTI-5 proposed rule to reduce burden, strengthen interoperability, and expand patient access through standards-based APIs. However, we caution that removing numerous certification criteria, particularly those related to privacy, security, and AI transparency, could introduce unintended risks. We urge clearer safeguards, phased implementation, equity protections […]